As mentioned above, direct insulin treatment is undesirable for this group of disease states given the potential for creating a state of hypoglycemia and reduced efficacy as a function of insulin resistance associated with neurodegenerative disease. The gene discussed is INS; the disease is neurodegenerative disease.